Sustained Remission Off-Treatment (SROT) of TPO-RAs: The Burgos Ten-Step Eltrombopag Tapering Scheme

Background and Objectives: TPO-RAs (romiplostim/eltrombopag/avatrombopag) have broadly demonstrated high efficacy rates (59–88%), durable responses (up to three years) and a satisfactory safety profile in clinical trials. The effect of TPO-RAs is classically considered to be transient because platel...

Descripción completa

Detalles Bibliográficos
Autores principales: González-López, Tomás José, Provan, Drew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145072/
https://www.ncbi.nlm.nih.gov/pubmed/37109617
http://dx.doi.org/10.3390/medicina59040659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145072/
https://www.ncbi.nlm.nih.gov/pubmed/37109617
http://dx.doi.org/10.3390/medicina59040659

Ejemplares similares